Home Current Issue Previous Issues Published Ahead-of-Print Collections For Authors Journal Info
Skip Navigation LinksHome > July 2013 - Volume 20 - Issue 7 > Patterns of use of oral adjuvant endocrine therapy in Austra...
Menopause:
doi: 10.1097/GME.0b013e31827ce094
Original Articles

Patterns of use of oral adjuvant endocrine therapy in Australian breast cancer survivors 5 years from diagnosis

Bell, Robin J. MB, BS, PhD, MPH, FAFPHM1; Schwarz, Max MB, BS, FRACP, FACP, FAChPM2; Fradkin, Pamela MBBS1; Robinson, Penelope J. BBiomedSci (Hons), M Biostat1; Davis, Susan R. MB, BS, PhD, FRACP1

Editorial
Collapse Box

Abstract

Objective

Oral adjuvant endocrine therapy (OAET) substantially improves the survival of women with hormone receptor–positive (HR+) breast cancer. However, we reported previously that at 3 to 4 years after diagnosis, 18% of affected women are not using OAET primarily because of estrogen deficiency symptoms. The aim of this study was to determine the use of OAET in women with HR+ breast cancer 5 to 6 years from diagnosis.

Methods

Analysis was carried out using data from the Bupa Health Foundation’s Health and Wellbeing After Breast Cancer Study, a cohort study of 1,683 women with breast cancer who were recruited in Victoria, Australia between 2004 and 2006. All women completed an enrollment questionnaire within 12 months of diagnosis and an annual follow-up questionnaire (FQ) for 5 years. The fifth FQ was completed 5.7 years from the time of diagnosis. Use of OAET was self-reported in response to a series of questions.

Results

A minimal exposure to OAET of at least 5 years (OAET in all six FQs) was reported by 19.7% of the women (n = 212), and another 46.7% (n = 503) received a minimal exposure of at least 4 years (OAET in five questionnaires). In total, 82.1% (n = 883) of the women would have received at least 3 years of treatment (OAET in at least four questionnaires). Only 7.8% (n = 84) reported never using OAET.

Conclusions

Most women with HR+ breast cancer who survive at least 5 years have persisted with OAET despite the adverse effects of estrogen depletion.

© 2013 by The North American Menopause Society

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.